Polyxeni Karakosta1, Theano Roumeliotaki2, Georgia Chalkiadaki2, Katerina Sarri2, Maria Vassilaki2, Maria Venihaki3, Niki Malliaraki3, Marilena Kampa4, Elias Castanas4, Manolis Kogevinas5, Christos Mantzoros6, Leda Chatzi2. 1. Department of Social Medicine, School of Medicine, University of Crete, Heraklion, Greece; Department of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, Greece. Electronic address: p_karakosta@hotmail.com. 2. Department of Social Medicine, School of Medicine, University of Crete, Heraklion, Greece. 3. Department of Clinical Chemistry-Biochemistry, School of Medicine, University of Crete, Heraklion, Greece. 4. Department of Experimental Endocrinology, School of Medicine, University of Crete, Heraklion, Greece. 5. Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; IMIM (Hospital del Mar Research Institute), Barcelona, Spain; CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain; National School of Public Health, Athens, Greece. 6. Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Abstract
OBJECTIVE: Leptin represents a potential modulator of developmental programming of childhood obesity. We investigated the association of cord blood leptin with growth trajectories from birth to early childhood. MATERIALS/ METHODS: We used data from the prospective mother-child cohort "Rhea", Crete, Greece. Cord blood samples from 642 neonates were collected. 578 (90%) children had complete follow up data from birth to 4years. We measured child weight, height, waist circumference, skinfold thicknesses, blood pressure, and serum lipids, leptin, adiponectin and C-reactive protein in early childhood (median 4.2years). We estimated growth trajectories from 3months up to 4years using random-effects linear-spline models. Multivariable logistic and linear regression models were used adjusting for confounders. RESULTS: Mean cord blood leptin levels were 7.3ng/mL (standard deviation: 6.3). Children with high cord blood leptin (>90th percentile) exhibited lower weight, height and body mass index from 6months to early childhood. Each SD increase in cord blood leptin was associated with lower weight at the age of 4 by 242g (95% CI: -416, -69). In a stratified analysis, the reverse association was observed in children born small for gestational age (p for interaction=0.001), and in those exhibiting rapid infant growth during the first 3months of life (p for interaction=0.002). Cord blood leptin levels were not associated with cardiometabolic risk factors at 4years. CONCLUSIONS: Long term programming effects of in utero exposure to leptin extends beyond infancy into early childhood. Further studies are needed to explore potential effect modification by intrauterine and early infancy growth patterns.
OBJECTIVE:Leptin represents a potential modulator of developmental programming of childhood obesity. We investigated the association of cord blood leptin with growth trajectories from birth to early childhood. MATERIALS/ METHODS: We used data from the prospective mother-child cohort "Rhea", Crete, Greece. Cord blood samples from 642 neonates were collected. 578 (90%) children had complete follow up data from birth to 4years. We measured child weight, height, waist circumference, skinfold thicknesses, blood pressure, and serum lipids, leptin, adiponectin and C-reactive protein in early childhood (median 4.2years). We estimated growth trajectories from 3months up to 4years using random-effects linear-spline models. Multivariable logistic and linear regression models were used adjusting for confounders. RESULTS: Mean cord blood leptin levels were 7.3ng/mL (standard deviation: 6.3). Children with high cord blood leptin (>90th percentile) exhibited lower weight, height and body mass index from 6months to early childhood. Each SD increase in cord blood leptin was associated with lower weight at the age of 4 by 242g (95% CI: -416, -69). In a stratified analysis, the reverse association was observed in children born small for gestational age (p for interaction=0.001), and in those exhibiting rapid infant growth during the first 3months of life (p for interaction=0.002). Cord blood leptin levels were not associated with cardiometabolic risk factors at 4years. CONCLUSIONS: Long term programming effects of in utero exposure to leptin extends beyond infancy into early childhood. Further studies are needed to explore potential effect modification by intrauterine and early infancy growth patterns.
Authors: Catherine O Buck; Melissa N Eliot; Karl T Kelsey; Aimin Chen; Heidi Kalkwarf; Bruce P Lanphear; Joseph M Braun Journal: Obesity (Silver Spring) Date: 2019-06-14 Impact factor: 5.002
Authors: Christos Bagias; Nithya Sukumar; Yonas Weldeselassie; Oyinlola Oyebode; Ponnusamy Saravanan Journal: Int J Environ Res Public Health Date: 2021-02-16 Impact factor: 3.390
Authors: Catherine O Buck; Melissa N Eliot; Karl T Kelsey; Antonia M Calafat; Aimin Chen; Shelley Ehrlich; Bruce P Lanphear; Joseph M Braun Journal: Pediatr Res Date: 2018-09-13 Impact factor: 3.756